Nepean Hospital is a 520-bed teaching hospital and regional trauma centre, providing tertiary referral services for the Nepean Blue Mountains Local Health District. Nepean Hospital is located at the base of the Blue Mountains in Kingswood, New South Wales, Australia.

There are 520 beds in Nepean Hospital.

During the past decade, Nepean Hospital conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 31 clinical trials were completed, i.e. on average, 36% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 22 clinical trials were completed. i.e. 53.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nepean Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 8 trials, followed by "Celgene" with 8 trials sponsored, "Kirby Institute" with 7 trials sponsored, "Pfizer" with 6 trials sponsored and "University of Sydney" with 6 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nepean Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 11 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 4 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator and "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator. Other collaborators include 152 different institutions and companies that were collaborators in the rest 141 trials.

According to Clinical.Site data, the most researched conditions in "Nepean Hospital" are "Crohn's Disease" (11 trials), "Ulcerative Colitis" (7 trials), "Pulmonary Arterial Hypertension" (5 trials), "Critical Illness" (4 trials) and "Crohn Disease" (4 trials). Many other conditions were trialed in "Nepean Hospital" in a lesser frequency.

Most popular intervention types in "Nepean Hospital" are "Drug" (94 trials), "Other" (18 trials), "Biological" (9 trials), "Procedure" (9 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "CP-690,550" (4 trials), "Filgotinib" (4 trials), "Lenalidomide" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Nepean Hospital" are 116 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Nepean Hospital". undefined are not yet recruiting, 34 are recruiting, 20 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 45 completed trials in Nepean Hospital, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Nepean Hospital, 7 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 13 trials that are defined as “Not Applicable".